Cardiometabolic conditions like diabetes, hypertension, and high cholesterol are major drivers of health care costs—and obesity is often the root cause. Addressing obesity doesn’t just lead to weight loss; it can also improve or even resolve costly, weight-related health conditions.

Learn how U.S. Steel addressed cardiometabolic conditions with a science-based, comprehensive obesity program. Key discussion highlights will include:

• The objectives of the program,
• How U.S. Steel navigated implementation challenges,
• U.S. Steel’s approach to anti-obesity medications, including GLP-1s, compounding and de-prescribing, and
• Outcomes to date.

Location & Time

Webinar

January 14, 12:00 p.m. - January 14, 01:00 p.m. E.T.

Speakers

• Dr. Melani Cheers, Corporate Medical Director, U.S. Steel Corporation
• Dr. Florencia Halperin, Leading Obesity Medicine Thought Leader & Chief Medical Officer, Form Health
• Jen Cressman, Chief Commercial Officer, Form Health